Methyl 2-hydroxy-3-(2-oxoethyl)benzoate, 95.0%, 250mg

(R)-1-phenyl-N-((R)-1-(4-(trifluoromethyl)phenyl)ethyl)ethanamine phthalate, 97%, 1g

Pipette à déplacement direct MICROMAN® E, 3 à 25 µl, 1 pièce

METHYL 3-(5-FLUORO-2-METHOXYPHENYL)-3-OXOPROPANOATE, 95.0%, 2g

(S)-10-Benzyl-23-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-6,9,12,15,18-pentaoxo-3-oxa-5,8,11,14,17-pentaazatricosan-1-oic acid, 95%, 1g

3-Indolemethanol>98.0%(HPLC)(N)5g

N,N-Diphenylformamide>98.0%(GC)25g

C-(1-Methyl-1 H -benzoimidazol-2-yl)-methylamine, 95.0%, 1g

tert-Butyl 1H-pyrrolo[2,3-b]pyridine-1-carboxylate, 95.0%, 10g

Ethyl 5-oxo-5,6,7,8-tetrahydroquinoline-3-carboxylate, 97%, 100mg

Methyl 2-oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-6-carboxylate, 97%, 1g

Caféine 99,5 +% pure 1 kilogramme

Pipette à insérer, 140 ml, 600 mm, 1 pièce